HARROW HEALTH, INC. (HROW) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 134 transactions totaling $15.3M, demonstrating a bullish sentiment with $10.5M in net insider flow. The most recent transaction on Jan 6, 2026 involved a sale of 20,000 shares valued at $1.1M.
No significant insider buying has been recorded for HROW in the recent period.
No significant insider selling has been recorded for HROW in the recent period.
Based on recent SEC filings, insider sentiment for HROW is bullish with an Insider Alignment Score of 84/100 and a net flow of $10.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at HARROW HEALTH, INC. (HROW) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading HROW stock, having executed 134 transactions in the past 90 days. The most active insider is Mark L. Baum (Executive), who has made 23 transactions totaling $37.8M.
Get notified when executives and directors at HROW file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Inc. Opaleye Management | Executive | Sale | 20,000 | $53.35 | $1.1M | Large |
| Dec 12, 2025 | L. Baum Mark | Executive | Option Exercise | 180,000 | $3.95 | $711.0K | Large |
| Dec 12, 2025 | L. Baum Mark | Executive | Payment | 79,994 | $47.06 | $3.8M | Large |
| Dec 12, 2025 | R. Boll Andrew | Executive | Payment | 26,665 | $47.06 | $1.3M | Large |
| Dec 12, 2025 | R. Boll Andrew | Executive | Option Exercise | 60,000 | $3.95 | $237.0K | |
| Jul 21, 2025 | L. Baum Mark | Executive | Option Exercise | 600,000 | $7.87 | $4.7M | Large |
| Jul 21, 2025 | L. Baum Mark | Executive | Payment | 313,338 | $37.08 | $11.6M | Large |
| Sep 11, 2024 | P. Saharek John | Executive | Payment | 45,140 | $41.37 | $1.9M | Large |
| Sep 11, 2024 | P. Saharek John | Executive | Option Exercise | 90,000 | $7.37 | $663.3K | Large |
| Apr 25, 2024 | Inc. Opaleye Management | Executive | Purchase | 20,000 | $9.97 | $199.4K | |
| Apr 24, 2024 | Inc. Opaleye Management | Executive | Purchase | 8,285 | $10.15 | $84.1K | |
| Apr 23, 2024 | Inc. Opaleye Management | Executive | Purchase | 11,715 | $10.29 | $120.5K | |
| Apr 19, 2024 | Inc. Opaleye Management | Executive | Purchase | 29,400 | $10.56 | $310.5K | |
| Mar 28, 2024 | Inc. Opaleye Management | Executive | Purchase | 50,000 | $12.82 | $641.0K | Large |
| Mar 22, 2024 | L. Baum Mark | Executive | Purchase | 9,000 | $11.59 | $104.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Payment(F) | 18 | $36.6M | 56.6% |
Purchase(P) | 67 | $12.9M | 19.9% |
Exercise(M) | 30 | $12.4M | 19.1% |
Sale(S) | 17 | $2.4M | 3.8% |
Exercise (Options)(X) | 2 | $349.1K | 0.5% |
Insiders at HARROW HEALTH, INC. are accumulating shares at an accelerated pace. With 10 insiders making 134 transactions totaling $12.9M in purchases versus $2.4M in sales, the net buying activity of $10.5M signals strong executive confidence. Mark L. Baum (Executive) leads the buying activity with $37.8M in transactions across all time.